Stay updated on M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    10%
    Check dated 2025-10-05T16:43:08.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Changed the revision tag from v3.0.2 to v3.1.0, updating the page's version/reference metadata.
    Difference
    0.2%
    Check dated 2025-09-28T10:07:52.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.6%
    Check dated 2025-09-14T00:20:04.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.6%
    Check dated 2025-09-06T21:27:10.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries. These changes enhance the clarity and relevance of the page's content.
    Difference
    36%
    Check dated 2025-08-30T15:51:30.000Z thumbnail image
  9. Check
    77 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T12:21:13.000Z thumbnail image

Stay in the know with updates to M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page.